Leadership Overview
Neuland Laboratories has 6 executives leading key functions including strategy, financial oversight, digital infrastructure, human capital, market expansion, and corporate communications.
Driven by a commitment to process chemistry excellence, Neuland Laboratories delivers high-quality active pharmaceutical ingredients and comprehensive chemistry services to the global pharmaceutical industry while maintaining rigorous regulatory standards.
Driven by a commitment to process chemistry excellence, Neuland Laboratories delivers high-quality active pharmaceutical ingredients and comprehensive chemistry services to the global pharmaceutical industry while maintaining rigorous regulatory standards.
Leadership Roles at Neuland Laboratories
Saharsh Davuluri - Chief Executive Officer & Managing Director
Saharsh Davuluri, the Chief Executive Officer & Managing Director at Neuland Laboratories, directs the overarching strategic vision for the organization. Overseeing the transition of complex process chemistry into large-scale cGMP manufacturing, the Chief Executive Officer & Managing Director ensures alignment between technical capabilities and global market demands. This leadership role involves navigating the regulatory landscape to maintain high quality standards across all API production lines. By fostering innovation in drug development services, Saharsh Davuluri drives the company toward sustainable growth and operational excellence. The Chief Executive Officer & Managing Director coordinates with the Board to refine long-term objectives, ensuring the firm remains a preferred partner for pharmaceutical clients worldwide. Through consistent focus on efficiency and scientific rigor, the Chief Executive Officer & Managing Director secures the competitive position of the firm within the international pharmaceutical manufacturing sector.
Abhijit Majumdar - Chief Financial Officer
Abhijit Majumdar, the Chief Financial Officer at Neuland Laboratories, manages the fiscal health and capital allocation strategies for the enterprise. Overseeing financial reporting and risk management, the Chief Financial Officer ensures the company maintains the liquidity necessary to support ongoing investments in chemistry-related services and infrastructure. This leadership role involves optimizing cost structures across manufacturing operations to enhance profitability while adhering to strict regulatory compliance. By analyzing market trends and financial performance, Abhijit Majumdar provides the data-driven insights required for strategic decision-making at the executive level. The Chief Financial Officer monitors global economic shifts to mitigate potential impacts on the supply chain and revenue streams. Through disciplined financial planning and transparent reporting, the Chief Financial Officer supports the long-term stability and growth objectives of the organization, ensuring resources align with the core mission of delivering high-quality pharmaceutical solutions.
Ajitabh Singh - Chief Information Officer
Ajitabh Singh, the Chief Information Officer at Neuland Laboratories, architects the digital infrastructure and data security frameworks supporting the company's manufacturing operations. Overseeing the integration of advanced information systems, the Chief Information Officer ensures seamless connectivity between research laboratories and production facilities. This leadership role involves implementing robust cybersecurity protocols to protect proprietary process chemistry data and client intellectual property. By modernizing digital workflows, Ajitabh Singh improves operational efficiency and data accuracy across the entire API development lifecycle. The Chief Information Officer collaborates with other executive leaders to leverage technology for enhanced supply chain visibility and regulatory reporting. Through the deployment of scalable IT solutions, the Chief Information Officer drives digital transformation initiatives that keep the firm at the forefront of the pharmaceutical industry. Ajitabh Singh maintains the integrity of all digital assets, ensuring reliable performance for global operations.
Hemchandra Peruvelli - Chief Human Resources Officer
Hemchandra Peruvelli, the Chief Human Resources Officer at Neuland Laboratories, designs the talent acquisition and organizational development strategies necessary to sustain a high-performance workforce. Overseeing recruitment, training, and employee engagement, the Chief Human Resources Officer ensures the company attracts top scientific talent capable of executing complex process chemistry projects. This leadership role involves fostering a culture of safety, compliance, and continuous learning within the regulatory environment. By implementing performance management systems, Hemchandra Peruvelli aligns individual contributions with the broader corporate goals of the firm. The Chief Human Resources Officer manages workforce planning to support the expansion of manufacturing capabilities and service offerings. Through the development of robust human capital policies, the Chief Human Resources Officer strengthens the organizational foundation, ensuring the company retains the expertise required to provide reliable solutions to the global pharmaceutical industry while maintaining operational excellence.
Raja Shekar - Deputy Manager, Material Planning & Chief Marketing Officer
Raja Shekar, the Deputy Manager, Material Planning & Chief Marketing Officer at Neuland Laboratories, manages the intersection of supply chain logistics and market positioning. Overseeing material planning, the Deputy Manager, Material Planning & Chief Marketing Officer ensures the availability of critical inputs for API manufacturing, thereby preventing production bottlenecks. Simultaneously, the Chief Marketing Officer role involves crafting the commercial strategy to promote the company's chemistry-related services to international pharmaceutical partners. This leadership role requires balancing inventory efficiency with the need to meet fluctuating market demand. By analyzing regional market requirements, Raja Shekar drives initiatives that expand the company's footprint in key pharmaceutical territories. The Deputy Manager, Material Planning & Chief Marketing Officer coordinates with production teams to ensure that marketing promises align with manufacturing capacity. Through this dual focus, the Deputy Manager, Material Planning & Chief Marketing Officer optimizes both the operational supply chain and the external brand presence.
Dorothy Paul - Chief Marketing & Communications Officer
Dorothy Paul, the Chief Marketing & Communications Officer at Neuland Laboratories, directs the corporate messaging and external engagement strategies for the organization. Overseeing brand identity and public relations, the Chief Marketing & Communications Officer ensures the company effectively communicates its expertise in process chemistry and API manufacturing to global stakeholders. This leadership role involves managing corporate communications to maintain a positive reputation within the highly regulated pharmaceutical sector. By developing targeted marketing campaigns, Dorothy Paul highlights the value of the company's end-to-end solutions to potential clients. The Chief Marketing & Communications Officer collaborates with executive leadership to ensure consistent messaging across all platforms and regions. Through strategic outreach and clear communication, the Chief Marketing & Communications Officer strengthens the firm's market position and fosters trust with partners. Dorothy Paul drives the narrative of innovation and reliability that defines the company's impact on the global pharmaceutical landscape.
Explore Leadership Teams in Manufacturing
Founded in 1949 and Headquartered in Mumbai, India, Ipca Laboratories Limited (IPCA) is a fully integrated pharmaceutical company manufacturing and marketing over 350 formulations and 80 API's covering various therapeutic segments.
Company Leadership

AP
AN
Eisai is a global pharmaceutical manufacturing company founded in 1941. The company develops and produces medicines while focusing on a human health care approach that extends beyond traditional pharmaceutical services. Eisai operates across multiple regions including North America, Europe, Asia Pacific, and the Middle East, with a strong presence in countries such as the United States, Japan, China, and the United Kingdom. The company maintains a significant focus on research and development in the pharmaceutical sector, with particular emphasis on patient-centered healthcare solutions. Eisai's business model encompasses both business-to-business and business-to-consumer operations, reflecting its comprehensive approach to healthcare delivery and pharmaceutical development.
Company Leadership

MM

Founded in 2004, Corona Remedies is headquartered in Thaltej, Gujarat. They are a pharmaceutical manufacturing company.
Company Leadership
BS

NS
Founded in 1969, Themis Medicar is a pharmaceutical company that specializes in manufacturing pharmaceuticals and medicinal chemicals for cardiology, pain management, anti-infectives, haematinics, and health and nutrition. Themis Medicare is located in India.
Company Leadership TD
RP
PN
MS